Spruce Biosciences, Inc.
SPRBD
$8.20
-$0.30-3.53%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 85.28% | 40.40% | -171.70% | 5.55% | 21.02% |
| Total Depreciation and Amortization | 16.67% | -33.33% | -10.00% | -16.67% | -20.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -204.66% | -56.00% | -14.73% | -31.24% | 7.77% |
| Change in Net Operating Assets | -834.66% | -53.63% | 204.76% | 52.13% | 25.86% |
| Cash from Operations | 30.64% | 38.45% | -124.19% | 16.95% | 25.75% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -0.25% | 0.25% | -0.25% | 0.25% | -0.25% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -71.11% |
| Repurchase of Common Stock | -- | -- | -- | 100.00% | -450.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 200.00% | -- | -- | -- | -- |
| Cash from Financing | 2.68% | 34.24% | -54.32% | -10.96% | -60.79% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 29.76% | 38.33% | -121.25% | 16.07% | 24.46% |